Login / Signup

Harnessing natural killer cells to target HIV-1 persistence.

Vinita R JoshiMarcus Altfeld
Published in: Current opinion in HIV and AIDS (2024)
Numerous studies focusing on targeting latently HIV-1-infected cells have emphasized a potential role of NK cells in these strategies. Our review highlights recent advances in harnessing NK cells in conjunction with latency reversal agents and other immunomodulatory therapeutics to target HIV-1 persistence.
Keyphrases